TWST:NASDAQ
Twist Bioscience Corp
$124.72
arrow_downward
-3.10%(-3.99) 1D
$124.70
arrow_downward
-0.02% (-0.020)bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$125.19
High
$128.12
Low
$123.75
Mkt. cap
8.26B
Avg. vol.
1.68M
Volume
900.90K
52-wk high
$155.43
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
Open
$125.19
High
$128.12
Low
$123.75
Mkt. cap
8.26B
Avg. vol.
1.68M
Volume
900.90K
52-wk high
$155.43
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
GuruFocus
·
10 minutes ago
Twist Bioscience Corp (TWST) Shares Fall 3.0% -- What GF Score o
Stock Traders Daily
·
1 day ago
Why (TWST) Price Action Is Critical for Tactical Trading
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp